NDC 52427-658

LOREEV XR

Lorazepam

LOREEV XR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Almatica Pharma Llc. The primary component is Lorazepam.

Product ID52427-658_9de134f2-bb27-8afb-6bbc-4ef9fa1f40b7
NDC52427-658
Product TypeHuman Prescription Drug
Proprietary NameLOREEV XR
Generic NameLorazepam
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2021-08-31
Marketing CategoryNDA /
Application NumberNDA214826
Labeler NameAlmatica Pharma LLC
Substance NameLORAZEPAM
Active Ingredient Strength1 mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 52427-658-30

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52427-658-30)
Marketing Start Date2021-09-24
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LOREEV XR" or generic name "Lorazepam"

NDCBrand NameGeneric Name
0187-0063Ativanlorazepam
0187-0064Ativanlorazepam
0187-0065Ativanlorazepam
0054-3532LorazepamLorazepam
0093-3425LorazepamLorazepam
0093-3426LorazepamLorazepam
0093-3427LorazepamLorazepam
0121-0770LorazepamLorazepam

Trademark Results [LOREEV XR]

Mark Image

Registration | Serial
Company
Trademark
Application Date
LOREEV XR
LOREEV XR
88324711 not registered Live/Pending
Alvogen Malta Operations Ltd.
2019-03-04
LOREEV XR
LOREEV XR
86914392 not registered Dead/Abandoned
Alvogen Malta Operations Ltd.
2016-02-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.